Home/Filings/4/0001628908-19-000011
4//SEC Filing

Stone Lydia 4

Accession 0001628908-19-000011

CIK 0001628908other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:12 PM ET

Size

7.3 KB

Accession

0001628908-19-000011

Insider Transaction Report

Form 4
Period: 2019-03-01
Stone Lydia
Principal Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2019-03-01+8,46523,855 total
  • Award

    Class A Common Stock Option (right to buy)

    2019-03-01+16,16416,164 total
    Exercise: $13.29Exp: 2029-03-01Class A Common Stock (16,164 underlying)
Footnotes (4)
  • [F1]Represents restricted stock units granted to Ms. Stone pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 25% annually beginning March 1, 2020.
  • [F3]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  • [F4]Securities vest at a rate of 25% annually beginning March 1, 2020.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001654824

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:12 PM ET
Size
7.3 KB